Nicole Riley | executive |
Ameet Mallik | executive |
Jose Carmona | executive |
Yun Zhong | analyst |
Michael Schmidt | analyst |
Mohamed Zaki | executive |
Kristen Harrington-Smith | executive |
Lut Ming Cheng | analyst |
Good day, and thank you for standing by. Welcome to the ADC Therapeutics First Quarter 2024 Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Nicole Riley, Head of Communications.